Clinical Trials Logo

Filter by:
NCT ID: NCT05338333 Completed - Presbyopia Clinical Trials

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Start date: May 27, 2022
Phase: N/A
Study type: Interventional

The primary objective of this study is to demonstrate noninferiority in visual acuity at distance when wearing the test contact lenses (LID210464) compared to the control contact lenses (AOHG MF) after 30 days of wear.

NCT ID: NCT05338216 Completed - Aphasia, Acquired Clinical Trials

Word Retrieval in the Wild in People With Post-Stroke Aphasia

Start date: December 19, 2022
Phase: N/A
Study type: Interventional

People with post-stroke aphasia (PWA) suffer from anomia, a condition where they know what they want to say but cannot retrieve the words. For PWA, word retrieval changes moment-to-moment, leading to diminished motivation to participate in conversations and disengagement from social interactions. In the real world, anomia variability and severity are compounded by contextual factors of communication exchanges (noise, dual-tasking). Ecological momentary assessment (EMA) involves in-situ measurement of a behavior over time during everyday life. EMA has promise for capturing real-world anomia, yet EMA methods have not been tested in PWA. Therefore, the aims of this pilot study are to (1) determine the relative feasibility of two types of smartwatch-delivered EMA (traditional-EMA and micro-EMA) in PWA and (2) determine the extent to which patient-specific factors relate to feasibility. Twenty PWA will be recruited and randomly assigned to either traditional-EMA or micro-EMA conditions. To target in-situ anomia, PWA will complete 36 picture-naming trials/day for three weeks, delivered either as a single trial 36 times per day (micro-EMA) or in four sets of nine trials/set per day (traditional-EMA). Due to the "at-a-glance" single trial delivery of micro-EMA, the investigators hypothesize that PWA in the micro-EMA condition will demonstrate better protocol adherence than PWA in the traditional-EMA condition. Older age, more severe cognitive-linguistic deficits, and greater discomfort with technology will be related to poorer compliance, lower completion, greater perceived burden, and lower intelligibility of naming audio recordings. This bench-to-bedside research will begin a translational path to implement EMA/micro-EMA into routine assessment of aphasia.

NCT ID: NCT05337878 Completed - Clinical trials for Healthy Participants

A Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants

Start date: October 15, 2018
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the safety, tolerability, and pharmacokinetics (PK) of single and multiple subcutaneous (SC) doses of Pelacarsen (ISIS 681257) in healthy Japanese participants.

NCT ID: NCT05337345 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants

Start date: May 2, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the drug levels of cendakimab delivered subcutaneously in healthy participants.

NCT ID: NCT05337293 Completed - Heart Failure Clinical Trials

Coping in Heart Failure Partnership Intervention

COPE-HF
Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and preliminary effectiveness of a 12-week support and problem-solving telephone-based intervention (COPE-HF) on heart failure self-care, depression, and healthcare utilization. Heart failure patients will be randomized to one of three groups (intervention, attention, control), with data collected at baseline and at 5, 9, and 13 weeks.

NCT ID: NCT05337280 Completed - Breast Cancer Clinical Trials

OA for Breast Cancer NAC Response

Start date: March 30, 2021
Phase: N/A
Study type: Interventional

This is an early research and development study. The objective of this study is to determine the feasibility of the Imagio OA/US Breast Imaging System to detect complete breast cancer pathologic response to neoadjuvant therapy as assessed by functional optoacoustic features, vascular features and relative degrees of oxygenation/deoxygenation

NCT ID: NCT05337254 Completed - Migraine Clinical Trials

A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Start date: March 5, 2021
Phase: Phase 1
Study type: Interventional

Single-center, single-dose, open-label, 5-period crossover (in each part), pharmacokinetic and safety study.

NCT ID: NCT05337150 Completed - Obesity Clinical Trials

Remotely Delivered Behavioral Weight Loss Using an Ad Libitum Plant-Based Diet Versus a Balanced Calorie Deficit Diet

Start date: May 29, 2022
Phase: N/A
Study type: Interventional

This pilot randomized controlled trial will compare a remotely delivered behavioral weight loss program with a balanced calorie deficit diet (the current gold-standard) to a behavioral weight loss program with an ad libitum whole food plant-based diet (WFPBD) amongst adults with overweight/obesity (N = 52). The 6-month intervention will consist of 3 months of moderate-intensity intervention (weekly online modules and brief coaching calls), then a low-intensity period (3 calls over 3-months). Assessments will occur at baseline, 6-weeks, 12-weeks, and post-treatment (6-months). Acceptability, dietary adherence, weight, quality of life, depressive symptoms, and subjective appetite will be assessed.

NCT ID: NCT05336994 Completed - Healthy Nutrition Clinical Trials

Vitamin/Mineral Absorption From Two Different Supplements

Start date: April 29, 2022
Phase: N/A
Study type: Interventional

The objective of this project is to evaluate the postprandial serum and plasma vitamin and mineral levels in healthy adult men and women between 18 and 32 years of age, following a single intake of a multivitamin and mineral supplement processed in two different ways.

NCT ID: NCT05336825 Completed - Vulvodynia Clinical Trials

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on young women and compare it to topical lidocaine.